Manufacturers trying to put into action these techniques will have to present robust validation facts to exhibit their equivalence to pharmacopoeial techniques. As these new technologies emerge, the WHO emphasizes the necessity of a radical chance assessment and validation method. How can sterility testing isolator manufacturers integrate